NeueHealth, Inc.
NEUE
$5.99
-$0.50-7.70%
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Revenue | 511.74M | 489.22M | 440.86M | 379.04M | -1.51B |
Total Other Revenue | 907.62M | 854.10M | 753.82M | 695.86M | 478.07M |
Total Revenue | 1.42B | 1.34B | 1.19B | 1.07B | -1.03B |
Cost of Revenue | 1.25B | 1.18B | 1.06B | 981.69M | -883.59M |
Gross Profit | 168.35M | 166.60M | 132.32M | 93.20M | -146.97M |
SG&A Expenses | 430.48M | 421.11M | 429.82M | 447.09M | 9.03M |
Depreciation & Amortization | 24.67M | 29.50M | 33.11M | 28.97M | 27.63M |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.71B | 1.63B | 1.53B | 1.46B | -846.93M |
Operating Income | -286.81M | -284.01M | -330.61M | -382.86M | -183.63M |
Income Before Tax | -760.40M | -378.54M | -417.81M | -476.75M | -250.70M |
Income Tax Expenses | -7.25M | -460.00K | 3.34M | 12.06M | 7.99M |
Earnings from Continuing Operations | -753.15 | -378.08 | -421.15 | -488.81 | -258.69 |
Earnings from Discontinued Operations | -720.65M | -818.70M | -938.34M | -881.85M | -401.52M |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -127.51M | -87.48M | -86.61M | -95.66M | -85.79M |
Net Income | -1.60B | -1.28B | -1.45B | -1.47B | -1.60B |
EBIT | -286.81M | -284.01M | -330.61M | -382.86M | -183.63M |
EBITDA | -262.13M | -254.51M | -297.93M | -347.17M | -148.84M |
EPS Basic | -208.40 | -168.86 | -189.29 | -191.59 | -250.38 |
Normalized Basic EPS | -42.14 | -35.86 | -38.82 | -43.63 | -11.74 |
EPS Diluted | -208.40 | -168.86 | -189.29 | -191.59 | -250.38 |
Normalized Diluted EPS | -42.14 | -35.86 | -38.82 | -43.63 | -11.74 |
Average Basic Shares Outstanding | 31.69M | 31.58M | 31.48M | 31.45M | 28.50M |
Average Diluted Shares Outstanding | 31.69M | 31.58M | 31.48M | 31.45M | 28.50M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |